Pulmonx (LUNG) last issued guidance on March 4, 2026 for fiscal year 2026. The company guided revenue in the range of $90.00M - $92.00M for the period.

Compared to prior guidance, Pulmonx raised its revenue forecast from a prior range of $89.00M - $90.00M.

Pulmonx has issued 18 guidance updates between May 3, 2022 and March 4, 2026. During this period, the company raised its outlook 6 times and lowered it 5 times, providing investors with insight into management's evolving expectations.